JPM vs PAPL
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
PAPL exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is experiencing significant operational failure with an operating margin of -115.70% and a catastrophic ROE of -203.43%. While the stock has seen a speculative short-term price surge (+181.2% in 1 month), this is decoupled from fundamentals as revenue continues to decline both YoY (-4.80%) and Q/Q (-15.04%). The lack of a Graham Number or Intrinsic Value reflects a lack of profitability and unsustainable valuation metrics.
Compare Another Pair
Related Comparisons
JPM vs PAPL: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Pineapple Financial Inc. (PAPL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.